Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2008

Web Exclusives

Puckering Up for AIDS Awareness

AIDSmeds in San Francisco: Highlights from CROI 2010

AIDS at the Oscars: Neglected, but Not Forgotten

» More

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

April 28, 2008

Better Antibiotics for Second-Line PCP Treatment

A combination of two oral antibiotics is more effective than the commonly used, yet side effect-prone, intravenous pentamidine for people who’ve failed their first AIDS-related pneumonia regimen, according to the authors of a new study published in the May 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS). Data supporting the use of clindamycin and primaquine is promising news for the roughly 10 percent of patients whose first course of treatment for Pneumcystis jirovecii pneumonia (PCP) doesn’t work.

Intravenous pentamidine is known for a range of serious side effects, including kidney toxicity, low blood pressure and low white blood cell count, and has been shown less effective as treatment for PCP than the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX), commonly known as Bactrim or Septra. For this reason, pentamidine is typically recommended only as second-line therapy for those who don’t respond effectively to their initial treatment choice, or as first-line treatment for people who cannot tolerate TMP-SMX. There are alternatives to pentamidine, but there has been little research to show how effective they may be in treating people who fail their first PCP regimen.

Thomas Benfield, MD, DMSci, from the Department of Infectious Diseases at Hvidovre University Hospital in Copenhagen, Denmark, and his colleagues conducted an analysis of 29 published studies, plus an additional 82 case reports from three European cities. In all, they were able to study the outcomes of 468 second-line PCP treatment episodes.

Benfield’s team found intravenous pentamidine was effective 44 percent of the time in curing cases of PCP in people who’d failed their first treatment. However, the cure rate was far higher (73 percent) in people who took clindamycin and primaquine, which are also less likely to cause serious side effects than pentamidine.

Benfield’s group recommends that clindamycin-primaquine now be used as second-line treatment in people with PCP who fail on TMP-SMX, or who cannot tolerate TMP-SMX.

Search: pentamidine, trimethoprim, sulfamethoxazole, TMP-SMX, Bactrim, Septra, clindamycin, primaquine, Thomas, Benfield, Hvidovre, University, pnumocystis, jerovecii, pneumonia, PCP


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    DJ10465
    Bronx
    New York


    plaboy022
    Phoenix
    Arizona


    ItcanBe
    Tampa
    Florida


    LivinLargeInMyMind
    Columbus
    Ohio
Click here to join POZ Personals!
Talk to Us
Poll
Question: Are women especially vulnerable to contracting HIV?
Yes
No

Survey
Peace of Mind

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy